Psilocybin May Help Combat Obesity and Diabetes
Research indicates low-dose psilocybin treatment can significantly reduce weight gain and insulin resistance in mice, opening avenues for new therapies.
Examining Trump’s Late-Night Behavior and Cognitive Health
The scrutiny of Donald Trump’s cognitive health has intensified, with critics suggesting his late-night social media activity indicates ‘sundowning’.
Seizure or Syncope? Differentiating the Two Conditions in Pets
This article helps veterinarians differentiate between seizures and syncope, providing insights for accurate diagnosis.
Managing Emerging Diseases in Veterinary Practices
This article discusses emerging disease management in veterinary settings, emphasizing modern strategies and challenges.
Why Your Pet Needs Their Leptospirosis Vaccine
Learn why keeping your pet’s leptospirosis vaccination up to date is essential for their health and safety.
Essential Learning for Veterinary Practice Managers
Discover valuable learning opportunities for veterinary practice managers at Fetch Nashville, focused on enhancing operational capabilities.
How GLP-1 Drugs Are Transforming Addiction Recovery
Recent studies show that GLP-1 drugs such as Ozempic may not only help with diabetes and obesity but could also provide significant benefits in treating alcohol and substance use disorders.
Funding Boost for Dog Longevity Drug Development
Loyal has raised $100 million to advance its canine longevity drug toward FDA approval, aiming for healthier senior dogs.
AI Revolutionizes Brain Disorder Diagnosis
A groundbreaking AI model is set to change the landscape of brain disorder diagnoses, offering quick and accurate results.
LSD Shows Promise in Protecting Against Seizures in Mice
Two studies suggest that LSD may have unexpected neuroprotective properties against severe seizures, prompting new discussions about its therapeutic potential.